Current Ratio in % of NeuBase Therapeutics, Inc. from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
NeuBase Therapeutics, Inc. quarterly Current Ratio history and change rate from Q1 2012 to Q3 2023.
  • NeuBase Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2023 was 411 %, a 50.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

NeuBase Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2023 411 -417 -50.3% 30 Sep 2023
Q2 2023 503 -496 -49.6% 30 Jun 2023
Q1 2023 711 -526 -42.5% 31 Mar 2023
Q4 2022 738 31 Dec 2022
Q3 2022 828 30 Sep 2022
Q2 2022 999 30 Jun 2022
Q1 2022 1,237 31 Mar 2022
Q3 2019 405 +90 +28.4% 30 Sep 2019
Q2 2019 364 +73 +25.1% 30 Jun 2019
Q1 2019 494 +203 +69.8% 31 Mar 2019
Q4 2018 434 +196 +82.1% 31 Dec 2018
Q3 2018 315 +57 +22% 30 Sep 2018
Q2 2018 291 +26 +9.9% 30 Jun 2018
Q1 2018 291 +25 +9.5% 31 Mar 2018
Q4 2017 238 -154 -39.2% 31 Dec 2017
Q3 2017 258 -175 -40.4% 30 Sep 2017
Q2 2017 265 -271 -50.5% 30 Jun 2017
Q1 2017 266 -405 -60.3% 31 Mar 2017
Q4 2016 392 -358 -47.7% 31 Dec 2016
Q3 2016 433 -162 -27.1% 30 Sep 2016
Q2 2016 536 +66 +14.1% 30 Jun 2016
Q1 2016 670 +340 +1% 31 Mar 2016
Q4 2015 749 +531 +2.4% 31 Dec 2015
Q3 2015 595 +321 +1.2% 30 Sep 2015
Q2 2015 469 +137 +41.1% 30 Jun 2015
Q1 2015 330 -679 -67.3% 31 Mar 2015
Q4 2014 218 -1,121 -83.7% 31 Dec 2014
Q3 2014 274 -182 -39.9% 30 Sep 2014
Q2 2014 333 +3 +0.84% 30 Jun 2014
Q1 2014 1,009 +865 +6% 31 Mar 2014
Q4 2013 1,339 +1,242 +12.8% 31 Dec 2013
Q3 2013 456 +394 +6.3% 30 Sep 2013
Q2 2013 330 +299 +9.7% 30 Jun 2013
Q1 2013 145 +117 +4.1% 31 Mar 2013
Q4 2012 96 31 Dec 2012
Q3 2012 62 30 Sep 2012
Q2 2012 30 30 Jun 2012
Q1 2012 28 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.